ERES controls not implemented during inspection walkthrough – CAPA and revalidation strategy


Published on 30/01/2026

Strategies for Addressing ERES Control Failures During Inspection Walkthroughs

When regulatory inspectors notice lapses in electronic records and electronic signatures (ERES) controls during walkthroughs, it poses a significant risk for pharmaceutical manufacturers. Such findings can lead to inspection failures, potential penalties, and increased scrutiny from regulatory bodies like the FDA, EMA, and MHRA. This article serves as a practical playbook for professionals in the pharmaceutical sector, enabling them to take swift actions in response to inadequacies in their ERES adherence.

To understand the bigger picture and long-term care, read this Electronic Records & Electronic Signatures (ERES).

By following the structured approach outlined here, manufacturing, quality control (QC), quality assurance (QA), engineering, and regulatory affairs (RA) teams will be equipped to effectively handle issues related to ERES compliance, from initial signals to long-term preventive strategies.

Symptoms/Signals on the Floor or in the Lab

Identifying early warning signs of inadequate ERES compliance is essential. Symptoms may include:

  • Missing Documentation: Absence of electronic
records supporting data critical to batch release.
  • Inconsistent Signatures: Discrepancies in electronic signatures due to system errors.
  • Uncontrolled Access: Unauthorized personnel accessing critical systems without proper electronic oversight.
  • Audit Trails Absence: Lack of complete audit trails for user activities in electronic systems.
  • Recognizing these signals can help initiate immediate containment actions and prevent further regulatory implications.

    Likely Causes

    To address the symptoms effectively, it is critical to categorize potential causes. Common factors can be classified into six categories:

    Category Potential Causes
    Materials Lack of user training on ERES compliance tools.
    Method Outdated procedures not aligned with current regulatory guidelines.
    Machine Malfunctioning electronic systems affecting log documentation.
    Man User errors during data entry or electronic sign-off.
    Measurement Insufficient monitoring of data integrity controls.
    Environment Improper facility layout leading to unauthorized access to sensitive systems.

    Immediate Containment Actions

    Within the first hour of detecting ERES control failures, teams should implement the following immediate containment actions:

    1. Isolate the Affected Systems: Suspend access to systems where non-compliance has been identified.
    2. Gather Initial Data: Collect logs and any relevant documentation that illustrates the control failures.
    3. Notify Key Stakeholders: Inform production, QC, and QA teams about the issues for collaborative investigation.
    4. Assess Impact: Evaluate whether any ongoing operations or processes may be affected by the breach.

    Investigation Workflow

    A thorough investigation is paramount in addressing ERES failures. Follow this streamlined workflow for data collection and interpretation:

    1. Collect Logs: Obtain audit trails, access logs, and system alerts.
    2. Interview Staff: Gather insights from operators and supervisors about any anomalies.
    3. Review Documentation: Examine relevant SOPs and training records for compliance with guidelines.
    4. Data Analysis: Look for patterns or repetitions in the issues encountered.

    Interpret data against established compliance standards (see ICH Q7 and FDA 21 CFR Part 11) to discern the nature and extent of the problem.

    Root Cause Tools

    Identifying the root cause of non-compliance is facilitated by several analytical tools. Choosing the right method aids significantly in the investigation:

    • 5-Why Analysis: Best for digging deeper into superficial symptoms to uncover underlying issues.
    • Fishbone Diagram: Effective for categorizing possible causes and visualizing relationships.
    • Fault Tree Analysis: Use is indicated for complex systems where failures can have multiple inter-linked causes.

    CAPA Strategy

    Establishing a robust Corrective and Preventive Action (CAPA) strategy is critical. This includes:

    • Correction: Immediate rectification of the non-compliance issue, restoring ERES controls to acceptable levels.
    • Corrective Action: Implement measures to prevent recurrence, such as retraining and updating procedures.
    • Preventive Action: Develop long-term strategies by revising the monitoring and oversight of ERES systems.

    Control Strategy & Monitoring

    Establish an effective control strategy to ensure ongoing compliance with ERES regulations:

    • Statistical Process Control (SPC): Employ SPC charts to monitor key process parameters.
    • Regular Sampling: Implement routine checks of electronic records against physical batch documents.
    • Alarms and Alerts: Set automatic alerts for any irregular access or data entry events.
    • Verification: Regular internal audits of ERES systems to ensure persistent adherence to compliance.

    Validation / Re-qualification / Change Control Impact

    Following any significant failures in ERES controls, a reassessment of system validation and re-qualification is often necessary:

    Related Reads

    • Validation: Ensure all electronic systems are revalidated to confirm they align with regulatory requirements.
    • Re-qualification: Assess if systems still perform reliably post-corrective actions.
    • Change Control: Implement change controls for any adjustments made to ERES systems during corrective actions.

    Inspection Readiness: What Evidence to Show

    To demonstrate compliance readiness to inspectors, maintain a clear audit trail of documentation:

    • Records: Documented evidence of all investigations and findings, including corrective actions taken.
    • Logs: Access and audit trail logs showing user activity during the relevant timeframe.
    • Batch Documents: Ensure batch records are completely aligned with requisite electronic records.
    • Deviations: Be prepared to discuss any deviations from established SOPs and how they were managed.

    FAQs

    What are ERES controls?

    ERES controls refer to the regulations governing electronic records and signatures to ensure data integrity and compliance in pharmaceutical manufacturing.

    Why is ERES compliance important?

    Compliance with ERES is vital for maintaining data integrity, ensuring the validity of educational outcomes, and adhering to regulatory requirements.

    How should we respond to ERES control failures?

    Implement immediate containment actions, conduct a thorough investigation, and establish a robust CAPA strategy to address and prevent recurrence.

    What tools can aid in root cause analysis?

    5-Why analysis, Fishbone diagrams, and Fault Tree analysis are effective tools in identifying the root causes of compliance failures.

    How can we prepare for inspections?

    Maintain thorough documentation, ensure readiness of audit trails, and regularly review and update training and procedures for all staff involved with ERES.

    What role does training play in ERES compliance?

    Ongoing training ensures that staff are aware of ERES policies and procedures and understand their responsibilities in upholding compliance.

    Are there consequences for ERES failures?

    Yes, non-compliance can lead to significant regulatory action, ranging from observations on inspections to recalls and legal implications.

    What should we monitor in our ERES systems?

    Monitor user access, data entry accuracy, and system performance to detect any anomalies or trends that may indicate compliance risks.

    How often should we audit our ERES systems?

    Regular internal audits should be scheduled at defined intervals, typically every 6-12 months, to ensure ongoing compliance and identify potential issues early.

    What is the significance of audit trails?

    Audit trails provide a verifiable record of all actions taken within an ERES system, essential for demonstrating compliance and facilitating investigations.

    Can CAPA actions improve ERES compliance?

    Yes, a well-implemented CAPA strategy can address identified issues and establish preventative measures to enhance overall compliance in the long term.

    What are common misconceptions about ERES systems?

    One major misconception is that electronic systems are ‘set and forget’. Continuous monitoring and regular updates are necessary to maintain compliance.

    Pharma Tip:  Record retention failures during inspection walkthrough – 21 CFR Part 11 compliance gaps